Proactiveinvestors Australia - Health Care, Equipment & Services RSS feed http://www.proactiveinvestors.com.au Proactiveinvestors Australia - Health Care, Equipment & Services feed en Sun, 21 Jan 2018 17:07:17 +1100 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com action@proactiveinvestors.com AtCor Medical signs $1 million contract with international pharmaceutical company http://www.proactiveinvestors.com.au/companies/news/188845/atcor-medical-signs-1-million-contract-with-international-pharmaceutical-company-188845.html Fri, 15 Dec 2017 13:00:00 +1100 http://www.proactiveinvestors.com.au/companies/news/188845/atcor-medical-signs-1-million-contract-with-international-pharmaceutical-company-188845.html Uscom to lift cash balance to advance medical device commercialisation strategy http://www.proactiveinvestors.com.au/companies/news/188832/uscom-to-lift-cash-balance-to-advance-medical-device-commercialisation-strategy-188832.html Fri, 15 Dec 2017 10:06:00 +1100 http://www.proactiveinvestors.com.au/companies/news/188832/uscom-to-lift-cash-balance-to-advance-medical-device-commercialisation-strategy-188832.html Orthocell secures European patent for unique tissue repair technology http://www.proactiveinvestors.com.au/companies/news/188091/orthocell-secures-european-patent-for-unique-tissue-repair-technology-188091.html Fri, 01 Dec 2017 15:05:00 +1100 http://www.proactiveinvestors.com.au/companies/news/188091/orthocell-secures-european-patent-for-unique-tissue-repair-technology-188091.html Genera Biosystems enters potential company making partnership http://www.proactiveinvestors.com.au/companies/news/187787/genera-biosystems-enters-potential-company-making-partnership-187787.html Mon, 27 Nov 2017 10:27:00 +1100 http://www.proactiveinvestors.com.au/companies/news/187787/genera-biosystems-enters-potential-company-making-partnership-187787.html Holista CollTech secures distribution rights for unique algae supplement http://www.proactiveinvestors.com.au/companies/news/187183/holista-colltech-secures-distribution-rights-for-unique-algae-supplement-187183.html Tue, 14 Nov 2017 11:19:00 +1100 http://www.proactiveinvestors.com.au/companies/news/187183/holista-colltech-secures-distribution-rights-for-unique-algae-supplement-187183.html Orthocell secures European market authorisation for medical device http://www.proactiveinvestors.com.au/companies/news/187006/orthocell-secures-european-market-authorisation-for-medical-device-187006.html Fri, 10 Nov 2017 08:43:00 +1100 http://www.proactiveinvestors.com.au/companies/news/187006/orthocell-secures-european-market-authorisation-for-medical-device-187006.html Orthocell's European regulatory approval may be on the horizon http://www.proactiveinvestors.com.au/companies/news/186904/orthocell-s-european-regulatory-approval-may-be-on-the-horizon-186904.html Wed, 08 Nov 2017 10:17:00 +1100 http://www.proactiveinvestors.com.au/companies/news/186904/orthocell-s-european-regulatory-approval-may-be-on-the-horizon-186904.html Brain Resource targets cash boost ahead of product commercialisation http://www.proactiveinvestors.com.au/companies/news/185986/brain-resource-targets-cash-boost-ahead-of-product-commercialisation-185986.html Mon, 23 Oct 2017 13:43:00 +1100 http://www.proactiveinvestors.com.au/companies/news/185986/brain-resource-targets-cash-boost-ahead-of-product-commercialisation-185986.html Innate's multiple sclerosis trials prove unsuccessful, new direction sought http://www.proactiveinvestors.com.au/companies/news/185913/innate-s-multiple-sclerosis-trials-prove-unsuccessful-new-direction-sought-185913.html Fri, 20 Oct 2017 10:04:00 +1100 http://www.proactiveinvestors.com.au/companies/news/185913/innate-s-multiple-sclerosis-trials-prove-unsuccessful-new-direction-sought-185913.html MedAdvisor to take health-tech strategy to investors http://www.proactiveinvestors.com.au/companies/news/185911/medadvisor-to-take-health-tech-strategy-to-investors-185911.html Fri, 20 Oct 2017 09:27:00 +1100 http://www.proactiveinvestors.com.au/companies/news/185911/medadvisor-to-take-health-tech-strategy-to-investors-185911.html REVA Medical crosses a milestone by implanting naturally dissolvable stent http://www.proactiveinvestors.com.au/companies/news/185609/reva-medical-crosses-a-milestone-by-implanting-naturally-dissolvable-stent-185609.html Mon, 16 Oct 2017 13:32:00 +1100 http://www.proactiveinvestors.com.au/companies/news/185609/reva-medical-crosses-a-milestone-by-implanting-naturally-dissolvable-stent-185609.html Avita Medical pauses trading to make arrangements http://www.proactiveinvestors.com.au/companies/news/185216/avita-medical-pauses-trading-to-make-arrangements-185216.html Mon, 09 Oct 2017 10:05:00 +1100 http://www.proactiveinvestors.com.au/companies/news/185216/avita-medical-pauses-trading-to-make-arrangements-185216.html AirXpanders increases production capacity of its tissue expander system http://www.proactiveinvestors.com.au/companies/news/184715/airxpanders-increases-production-capacity-of-its-tissue-expander-system-184715.html Thu, 28 Sep 2017 14:16:00 +1000 http://www.proactiveinvestors.com.au/companies/news/184715/airxpanders-increases-production-capacity-of-its-tissue-expander-system-184715.html Avita Medical seeks FDA approval for its cell harvesting device in the U.S. http://www.proactiveinvestors.com.au/companies/news/184773/avita-medical-seeks-fda-approval-for-its-cell-harvesting-device-in-the-us-184773.html Thu, 28 Sep 2017 08:31:00 +1000 http://www.proactiveinvestors.com.au/companies/news/184773/avita-medical-seeks-fda-approval-for-its-cell-harvesting-device-in-the-us-184773.html Cynata Therapeutics wins U.S. patent for stem cell technology http://www.proactiveinvestors.com.au/companies/news/184641/cynata-therapeutics-wins-us-patent-for-stem-cell-technology-184641.html Wed, 27 Sep 2017 15:40:00 +1000 http://www.proactiveinvestors.com.au/companies/news/184641/cynata-therapeutics-wins-us-patent-for-stem-cell-technology-184641.html Avita Medical secures US$24.3M for paediatric burn care research http://www.proactiveinvestors.com.au/companies/news/184338/avita-medical-secures-us243m-for-paediatric-burn-care-research-184338.html Thu, 21 Sep 2017 11:57:00 +1000 http://www.proactiveinvestors.com.au/companies/news/184338/avita-medical-secures-us243m-for-paediatric-burn-care-research-184338.html Holista CollTech snaps up asset http://www.proactiveinvestors.com.au/companies/news/184172/holista-colltech-snaps-up-asset-184172.html Tue, 19 Sep 2017 11:14:00 +1000 http://www.proactiveinvestors.com.au/companies/news/184172/holista-colltech-snaps-up-asset-184172.html Medlab Clinical wins patent for its unique anti-depression product http://www.proactiveinvestors.com.au/companies/news/184105/medlab-clinical-wins-patent-for-its-unique-anti-depression-product-184105.html Mon, 18 Sep 2017 12:56:00 +1000 http://www.proactiveinvestors.com.au/companies/news/184105/medlab-clinical-wins-patent-for-its-unique-anti-depression-product-184105.html Race Oncology crosses a milestone in chemotherapy drug development http://www.proactiveinvestors.com.au/companies/news/183823/race-oncology-crosses-a-milestone-in-chemotherapy-drug-development-183823.html Wed, 13 Sep 2017 07:36:00 +1000 http://www.proactiveinvestors.com.au/companies/news/183823/race-oncology-crosses-a-milestone-in-chemotherapy-drug-development-183823.html Orthocell treats first patient in clinical trial of its injection for shoulder injury http://www.proactiveinvestors.com.au/companies/news/183406/orthocell-treats-first-patient-in-clinical-trial-of-its-injection-for-shoulder-injury-183406.html Wed, 06 Sep 2017 00:42:00 +1000 http://www.proactiveinvestors.com.au/companies/news/183406/orthocell-treats-first-patient-in-clinical-trial-of-its-injection-for-shoulder-injury-183406.html Ellex Medical Lasers expanding production capacity to meet rising demand http://www.proactiveinvestors.com.au/companies/news/183333/Ellex-Medical-Lasers-expanding-production-capacity-to-meet-rising-demand-183333.html Mon, 04 Sep 2017 08:47:00 +1000 http://www.proactiveinvestors.com.au/companies/news/183333/Ellex-Medical-Lasers-expanding-production-capacity-to-meet-rising-demand-183333.html Traditional Therapy Clinics’ shares ride higher on expansion in China http://www.proactiveinvestors.com.au/companies/news/183330/traditional-therapy-clinics-shares-ride-higher-on-expansion-in-china Mon, 04 Sep 2017 07:47:00 +1000 http://www.proactiveinvestors.com.au/companies/news/183330/traditional-therapy-clinics-shares-ride-higher-on-expansion-in-china Cynata Therapeutics process meets Health Canada expectations http://www.proactiveinvestors.com.au/companies/news/183210/cynata-therapeutics-process-meets-health-canada-expectations-183210.html Thu, 31 Aug 2017 14:05:00 +1000 http://www.proactiveinvestors.com.au/companies/news/183210/cynata-therapeutics-process-meets-health-canada-expectations-183210.html Resonance Health to launch pioneering liver-iron-concentration test http://www.proactiveinvestors.com.au/companies/news/182710/resonance-health-to-launch-pioneering-liver-iron-concentration-test-182710.html Mon, 21 Aug 2017 15:04:00 +1000 http://www.proactiveinvestors.com.au/companies/news/182710/resonance-health-to-launch-pioneering-liver-iron-concentration-test-182710.html Cyclopharm begins nuclear imaging trial to detect respiratory diseases http://www.proactiveinvestors.com.au/companies/news/182639/cyclopharm-begins-nuclear-imaging-trial-to-detect-respiratory-diseases-182639.html Fri, 18 Aug 2017 11:16:00 +1000 http://www.proactiveinvestors.com.au/companies/news/182639/cyclopharm-begins-nuclear-imaging-trial-to-detect-respiratory-diseases-182639.html Anatara Lifesciences to reveal details on animal health company http://www.proactiveinvestors.com.au/companies/news/182568/anatara-lifesciences-to-reveal-details-on-animal-health-company-182568.html Thu, 17 Aug 2017 11:37:00 +1000 http://www.proactiveinvestors.com.au/companies/news/182568/anatara-lifesciences-to-reveal-details-on-animal-health-company-182568.html Optiscan Imaging shares ride higher after securing first U.S. order http://www.proactiveinvestors.com.au/companies/news/182501/optiscan-imaging-shares-ride-higher-after-securing-first-us-order-182501.html Wed, 16 Aug 2017 12:47:00 +1000 http://www.proactiveinvestors.com.au/companies/news/182501/optiscan-imaging-shares-ride-higher-after-securing-first-us-order-182501.html Traditional Therapy Clinics bags $2M to roll out more clinics in China http://www.proactiveinvestors.com.au/companies/news/182341/traditional-therapy-clinics-bags-2m-to-roll-out-more-clinics-in-china-182341.html Mon, 14 Aug 2017 09:21:00 +1000 http://www.proactiveinvestors.com.au/companies/news/182341/traditional-therapy-clinics-bags-2m-to-roll-out-more-clinics-in-china-182341.html ITL extends contract with large U.S. community blood bank http://www.proactiveinvestors.com.au/companies/news/181377/itl-extends-contract-with-large-us-community-blood-bank-181377.html Tue, 25 Jul 2017 11:00:00 +1000 http://www.proactiveinvestors.com.au/companies/news/181377/itl-extends-contract-with-large-us-community-blood-bank-181377.html Innate Immunotherapeutics reviews additional trial data, same result http://www.proactiveinvestors.com.au/companies/news/181243/innate-immunotherapeutics-reviews-additional-trial-data-same-result-181243.html Fri, 21 Jul 2017 09:00:00 +1000 http://www.proactiveinvestors.com.au/companies/news/181243/innate-immunotherapeutics-reviews-additional-trial-data-same-result-181243.html New facility 'essential to Concepta PLC's growth' says CEO Erik Henau http://www.proactiveinvestors.com.au/companies/stocktube/6347 Concepta PLC (LON:CPT) has taken out  a ten year lease on a new manufacturing facility in Doncaster.
CEO Erik Henau tells Proactive: ''It'll be the UK manufacturing side for our diagnostic tests which fit our MyLotus meter - so initially we'll be making the pregnancy test and the ovulation test in the UK with processes that are completely controlled by ourselves.'' The factory will be ready in the first quarter of 2017, with all customer-facing staff also to be based there. In terms of capacity, Henau added ''we have huge expectations and the market is very large both in China, the UK  ... it's a global issue we're addressing''.

]]>
Tue, 08 Nov 2016 23:18:00 +1100 http://www.proactiveinvestors.com.au/companies/stocktube/6347
Biovault tie-up a 'landmark development' for WideCells Group PLC http://www.proactiveinvestors.com.au/companies/stocktube/6337 WideCells Group’s (LON:WDC) subsidiary CellPlan has signed a non-binding letter of intent to offer its stem cell treatment insurance to clients of the human tissue storage facility Biovault Technical. Biovault has a register of over 25,000 customers which WideCells will have access to for an initial five year term.

WideCells CEO chief executive João Andrade tells Proactive: ''This is a very important landmark for us because we have developed the product and now the market's responding positively to it. This letter of intent will allow us to have access directly to around 25,000 clients who Biovault currently has through their own company and also its affiliates and that will enable us to be able to rollout CellPlan during the course of next year''.

''What we'll be doing, until the end of this year, is developing together with Biovault, an implementation plan and a market roll out plan because Biovault is operating in several countries - not just in the UK'',  Andrade added.

]]>
Mon, 07 Nov 2016 22:17:00 +1100 http://www.proactiveinvestors.com.au/companies/stocktube/6337
Deltex Medical Group PLC poised for rapid US growth http://www.proactiveinvestors.com.au/companies/stocktube/5928 Deltex Medical Group plc (LON:DEMG) would not be the first British company to find a more welcome reception in the USA than in its home, and it has just announced that its US sales have overtaken those from the UK for the first time.
Chief executive officer Ewan Philips tells Proactive Investors that the company now has 27 “platform accounts” in the USA, which will form a bridgehead for its US sales initiatives. Sadly, back in Blighty, despite masses of evidence pointing to the superiority of its oesophageal Doppler monitoring technology (ODM) and a recommendation that it should be taken up by UK hospitals, inertia rules the day. Philips says the company has reverted to its old sales policy of “knocking on surgery doors” to persuade surgeons of the benefits of ODM.

]]>
Fri, 09 Sep 2016 00:08:00 +1000 http://www.proactiveinvestors.com.au/companies/stocktube/5928
Compumedics' Ltd Chairman and CEO David Burton talks to Proactive Investors TV http://www.proactiveinvestors.com.au/companies/stocktube/5670 ASX:CMP) is a revenue generating medical device company, with its share price doubling in the past year. Opportunity to continue its strong sales growth in China, and to expand into other global markets. ]]> Fri, 06 May 2016 12:01:00 +1000 http://www.proactiveinvestors.com.au/companies/stocktube/5670 Uscom's CEO Rob Phillips talks revenue growth at Proactive's Luncheons http://www.proactiveinvestors.com.au/companies/stocktube/5910 ASX:UCM) is a revenue generating cardiovascular medical technology company that is carrying out due diligence to acquire Thor Laboratories KFT. ]]> Fri, 18 Sep 2015 09:00:00 +1000 http://www.proactiveinvestors.com.au/companies/stocktube/5910 Pulse Health CEO talks about the private hospital sector and Eden acquisition http://www.proactiveinvestors.com.au/companies/stocktube/5867 ASX:PHG) is neatly positioned in the private health sector as an integrated health services provider in Australia ]]> Tue, 07 Aug 2012 10:05:00 +1000 http://www.proactiveinvestors.com.au/companies/stocktube/5867